New Strong Sell Stocks for August 11th

Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:


Fastly, Inc.


FSLY

operates an edge cloud platform for processing, serving, and securing its customer’s applications. The Zacks Consensus Estimate for its current year earnings has been revised 47.5% downward over the last 30 days.


Largo Resources Ltd.


LGO

operates as a natural resource development and exploration company. The Zacks Consensus Estimate for its current year earnings has been revised 7.3% downward over the last 30 days.


PetIQ, Inc.


PETQ

operates as a pet medication and wellness company. The Zacks Consensus Estimate for its current year earnings has been revised 10.6% downward over the last 30 days.


Valero Energy Corporation


VLO

manufactures, markets, and sells transportation fuels and petrochemical products. The Zacks Consensus Estimate for its current year earnings has been revised 61.5% downward over the last 30 days.


iCAD, Inc.


ICAD

provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer. The Zacks Consensus Estimate for its current year earnings has been revised 14.3% downward over the last 30 days.

View the entire

Zacks Rank #5 List.


Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released

Century of Biology: 7 Biotech Stocks to Buy Right Now

to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.


See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.

Click to get this free report


To read this article on Zacks.com click here.


Zacks Investment Research

If You Liked This Article Click To Share

Health